{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:26:45Z","timestamp":1759422405560},"reference-count":112,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1080\/14740338.2020.1804551","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T06:57:20Z","timestamp":1596178640000},"page":"1143-1154","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular safety risks associated with gout treatments"],"prefix":"10.1080","volume":"19","author":[{"given":"Giovanna","family":"Rosas","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Gaffo","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Rahn","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2549-x"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/BF00163854"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205304"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215933"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1756"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.06.005"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302535"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.113357"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115593"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10443"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11496"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0684-z"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.06.017"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199865"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2012.07.009"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1186\/ar1906"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.05.046"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10370"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.092839"},{"key":"cit0021","first-page":"85","volume":"80","author":"Acevedo A","year":"2016","journal-title":"Conn Med"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004177"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20344"},{"key":"cit0024","first-page":"677","volume":"8","author":"Jossa F","year":"1994","journal-title":"J Hum Hypertens"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.18.2404"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02133.x"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.10.045"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-1-199907060-00003"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116491"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.11.6858"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.9.e85"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000056762.69302.46"},{"key":"cit0033","unstructured":"Allopurinol approval package Fl."},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0227"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem056a"},{"key":"cit0036","unstructured":"U.S. Food & Drug adminsitratio (FDA). Product information Zyloprim (Allopurinol). 2018. (Updated 2020 Jun 29, Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/016084s044lbl.pdf.)"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099102"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.01.013"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146172"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.3.229"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-017-0513-6"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0692-2"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0816-6"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2017.01.004"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01580210"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.11.016"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.04.005"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90127-9"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.074"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2010.532323"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305683"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.8.924"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10771016"},{"key":"cit0054","unstructured":"U.S. Food & Drug adminsitratio (FDA).ULORIC (febuxostat) tablet for oral use. 2017. (Updated 2020 Jun 29. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021856s011lbl.pdf.)"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.11.033"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050373"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez189"},{"key":"cit0058","first-page":"393","volume":"10","author":"Foody J","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.03.001"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1593-0"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-12-11"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz119"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710895"},{"key":"cit0064","unstructured":"Cardiovascular Safety in Gout: Interpreting Data From the CARES Trial. 2019. (Updated 2020 Jun 24, at https:\/\/www.thecardiologyadvisor.com\/home\/topics\/chd\/cardiovascular-safety-in-gout-interpreting-data-from-the-cares-trial\/.)"},{"key":"cit0065","first-page":"72(6):744\u2013760","author":"FitzGerald JD","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4396-4"},{"key":"cit0067","first-page":"1245","volume":"321","author":"Voelker R","year":"2019","journal-title":"JAMA"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-13-0082"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2013.846358"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2017.11.006"},{"key":"cit0071","unstructured":"AstraZeneca. Zurampic (lesinurad) approved by US FDA for patients with gout. Updated February 24, 2020. Avaialble from: https:\/\/www.astrazeneca-us.com\/media\/press-releases\/2015\/zurampic-lesinurad-approved-by-us-fda-for-patients-20151222.html"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-017-0461-y"},{"key":"cit0073","unstructured":"U.S. Food & Drug adminsitratio (FDA).ZURAMPIC\u00ae(lesinurad) tablets, for oral use 2015. Updated 2020 Jun 29 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/207988lbl.pdf.)"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209213"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S114455"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1002\/art.40159"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1002\/art.39840"},{"key":"cit0078","volume-title":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). LiverTox: clinical and research information on drug-induced liver injury","year":"2012"},{"key":"cit0079","unstructured":"U.S. Food & Drug adminsitratio (FDA).KRYSTEXXA\u00ae (pegloticase). 2012. Updated 2020 Jun 29. Avaialble from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/125293s034lbl.pdf.)"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12727"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.08.017"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1002\/art.23810"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001072107"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1169"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.12.010"},{"key":"cit0086","unstructured":"U.S. Food & Drug adminsitratio (FDA).COLCRYS (colchicine, USP) tablets, for oral use. 2020. Updated 2020 Jun 29. Avaialble from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/022352s026lbl.pdf#page=25.)"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.027"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.11.006"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90624-V"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516"},{"key":"cit0092","unstructured":"U.S. Food & Drug adminsitratio (FDA).ILARIS\u00ae (canakinumab) for injection, for subcutaneous use. 2016. Updated 2020 Jun 29. Avaialble from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/125319Orig1s085,086,087Lbl.pdf.)"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.7326\/L19-0123"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.4566"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel071"},{"key":"cit0097","unstructured":"U.S. Food & Drug adminsitratio (FDA). FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. 2015. Updated 2020 Jun 25. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-strengthens-warning-non-aspirin-nonsteroidal-anti-inflammatory.)"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61490-7"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1041606"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611593"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.031492"},{"key":"cit0103","first-page":"I","volume":"141","year":"2004","journal-title":"Ann Intern Med"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.020180"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-10-200411160-00007"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0432"},{"key":"cit0107","first-page":"668","volume":"96","author":"Noss MR","year":"2017","journal-title":"Am Fam Physician"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"cit0109","first-page":"20","author":"Pascart T","year":"2020","journal-title":"Joint Bone Spine"},{"key":"cit0110","first-page":"158","volume":"39","author":"Araujo F","year":"2014","journal-title":"Acta Reumatol Port"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13266"},{"key":"cit0112","first-page":"324","volume":"55","author":"Yamanaka H","year":"2012","journal-title":"Japan Med Assoc J"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2020.1804551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:05:58Z","timestamp":1620450358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2020.1804551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":112,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.1080\/14740338.2020.1804551"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2020.1804551","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}